LENZ Therapeutics, Inc. LENZ
3.92
0.20
5.38%
as of 25 Sep
- Market cap
- $117.4M
- P/E
- 0.0×
Follow LENZ
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | — | — | — | — | — | — | — |
P/S ratio |
0.00 | — | — | — | — | — | — | — |
P/FCF ratio |
0.00 | — | — | — | — | — | — | — |
P/Operating CF |
(13.96) | — | — | — | — | — | — | — |
P/B ratio |
1.62 | — | — | — | — | — | — | — |
Price to Tangible BV |
1.62 | — | — | — | — | — | — | — |
EV/Sales |
0.00 | — | — | — | — | — | — | — |
EV/EBITDA |
0.00 | — | — | — | — | — | — | — |
EV/Operating CF |
(2.49) | — | — | — | — | — | — | — |
EV/FCF |
(2.46) | — | — | — | — | — | — | — |
Quick Ratio |
13.81 | 20.10 | 3.55 | 20.57 | 31.04 | 0.62 | 0.00 | — |
Current Ratio |
14.23 | 20.36 | 3.63 | 21.11 | 31.44 | 0.66 | 0.00 | — |
Net Debt/EBITDA |
3.22 | 3.57 | 0.90 | 2.52 | 6.31 | 1.48 | (75.83) | — |
Debt/Assets |
0.00% | 0.00% | 0.00% | 1.26% | 0.00% | 0.00% | 36,750.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | (0.99) | — |
Asset Turnover |
0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.84 | 1.19 | 0.86 | 0.87 | 0.75 | 0.13 | 0.17 | — |
Capex/Depreciation |
(2.88) | (8.07) | 0.03 | (8.77) | (7.82) | (12.77) | — | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| (33.63%) | (89.37%) | (68.74%) | (29.71%) | (44.41%) | 202.21% | 0.32% | — | |
| (31.52%) | (34.84%) | (35.67%) | (27.92%) | (33.33%) | (605.88%) | (3,633.33%) | — | |
ROIC |
0.00% | 0.00% | 0.00% | (205.64%) | (534.02%) | 0.00% | 0.00% | — |
Return on Tangible Assets |
(29.18%) | (24.62%) | (143.42%) | (35.46%) | (18.81%) | 720.93% | 4.91% | — |
Average Days of Receivables |
6.29 | — | — | — | — | — | — | — |
Research and Development Expense of Revenue |
97.81% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | — |
Selling, General and Administrative Expense of Revenue |
477.46% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
65.73% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | — |
Graham Net Nets |
0.61 | — | — | — | — | — | — | — |
Graham Number |
0.00 | — | — | — | — | — | — | — |
Earnings Yield |
(17.56%) | — | — | — | — | — | — | — |
Free Cash Flow Yield |
(15.18%) | — | — | — | — | — | — | — |
Revenue per Share |
0.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF per Share |
(2.40) | (2.79) | (30.82) | (11.22) | (12.79) | (26.72) | 0.00 | — |
Capex per Share |
(0.03) | (0.02) | (0.02) | (0.84) | (1.39) | (4.73) | 0.00 | — |
Free Cash Flow per Share |
(2.43) | (2.81) | (30.84) | (12.06) | (14.18) | (31.45) | 0.00 | — |
Cash per Share |
10.15 | 9.83 | 33.59 | 34.21 | 91.22 | 60.71 | 0.00 | — |
Shareholders Equity per Share |
9.87 | 9.59 | (47.33) | 37.79 | 92.93 | (200.39) | 0.00 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
9.87 | 9.59 | (47.33) | 37.79 | 92.93 | (200.39) | 0.00 | — |
Free Cash Flow |
(70.00) | (59.86) | (60.41) | (94.57) | (58.59) | (10.27) | (0.02) | — |
Working Capital |
280.23 | 201.51 | 48.73 | 262.32 | 369.59 | (10.94) | (2.22) | — |
Capital Expenditures |
(0.83) | (0.47) | (0.03) | (6.59) | (5.74) | (1.54) | — | — |
Net Current Asset Value |
279.88 | 200.70 | (95.84) | 249.75 | 363.80 | (66.87) | (2.22) | — |
EV/EBIT |
0.00 | — | — | — | — | — | — | — |
Capex to Sales |
0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Net Profit Margin |
(430.25%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Price to Operating Income |
0.00 | — | — | — | — | — | — | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
0.24 | 0.09 | (19.30) | 0.03 | 0.11 | 0.08 | — | — |
Cash ROIC |
(12.20%) | (14.53%) | 224.51% | (19.45%) | (7.80%) | 22.33% | 271.43% | — |
Accounts Receivable Turnover |
0.00 | — | — | — | — | — | — | — |
Accounts Payable Turnover |
0.10 | 0.00 | 0.00 | 3.30 | 0.48 | 0.08 | — | — |
Inventory Turnover |
0.00 | — | — | 0.00 | 0.00 | 0.00 | — | — |
Average Days of Payables |
3,638.65 | 0.00 | 0.00 | 114.06 | 1,219.82 | 1,900.41 | — | — |
Days of Inventory on Hand |
2,563.73 | — | — | 0.00 | 0.00 | 0.00 | — | — |
Average Payables |
4.21 | 4.98 | 4.16 | 2.53 | 1.54 | 1.54 | — | — |
Average Assets |
260.59 | 142.84 | 196.14 | 361.94 | 212.28 | 11.29 | 0.00 | — |
Average Common Equity |
244.21 | 55.69 | 101.79 | 340.17 | 159.32 | (33.81) | (33.81) | — |
Columns are period end dates